Australian Pharaceutical
Industries has announced the
appointment of Kenneth W
Gunderson-Briggs as a senior
independent director.
Gunderson-Briggs was first
appointed to the API Board in May
2014.
The appointment follows the
previously announced retirement
of Michael Wooldridge as lead
independent director (PD 27 Nov
14), the position that can fulfil the
role of Chair when the Chair is
unable to act in that capacity due
to unavailability or conflict.The above article was sent to subscribers in Pharmacy Daily's issue from 03 Sep 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Sep 15
THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
A NEW study from the University of South Australia has discovered that an increased cardio-fitness level will reduce risk of death from any cause by nearly 20%.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.